image
Healthcare - Medical - Diagnostics & Research - NYSE - NL
$ 41.27
-1.95 %
$ 9.16 B
Market Cap
91.71
P/E
CASH FLOW STATEMENT
459 M OPERATING CASH FLOW
-35.76%
-87.7 M INVESTING CASH FLOW
87.94%
-434 M FINANCING CASH FLOW
-244.85%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Qiagen N.V.
image
Net Income 341 M
Depreciation & Amortization 205 M
Capital Expenditures -163 M
Stock-Based Compensation 47.1 M
Change in Working Capital -187 M
Others -22.7 M
Free Cash Flow 297 M

Cash Flow

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011 Dec-2010 Dec-2009 Dec-2008 Dec-2007 Dec-2006 Dec-2005 Dec-2004 Dec-2003 Dec-2002 Dec-2001 Dec-2000 Dec-1999 Dec-1998 Dec-1997 Dec-1996 Dec-1995
OPERATING CASH FLOW
Net Income 341.3 423.2 512.6 73.6 (41.5) 190.4 40.4 80.3 126.9 117.2 69.1 129.5 94.9 144.3 137.8 89.0 50.1 70.5 62.2 48.7 42.9 23.1 34.4 20.1 12.6 12.4 8.8 5.3 2.4
Depreciation & Amortization 205.3 208.4 214.9 210.0 231.5 206.4 216.4 213.1 191.5 200.8 199.4 197.9 167.4 142.8 120.4 105.7 62.6 30.0 25.0 23.0 25.8 24.7 15.1 10.5 7.8 5.8 4.9 2.5 1.8
Deferred Income Tax 10.7 (9.6) (5.3) (14.3) (55.4) (23.3) 39.6 (66.0) (37.2) (41.3) (68.1) (22.8) (31.9) (19.9) (10.6) (17.7) (1.7) 5.2 (2.2) (10.5) 12.2 5.0 (1.8) (5.4) (1.5) (1.0) (0.9) 0.4 0.3
Stock Based Compensation 47.1 49.5 38.4 40.9 65.9 40.1 34.4 28.3 27.6 42.2 37.9 25.4 19.5 13.6 9.7 9.8 8 982.0 326.0 0 0 0 0 0 0 0 0 0 0 0
Other Operating Activities 41.9 75.6 8.4 165.2 174.6 41.0 23.2 75.6 89.9 47.9 15.0 (1.3) 37.7 (14.1) (5.5) 4.2 (8 952.4) (325.2) 10.0 12.6 8.4 (1.9) 16.3 25.7 6.2 100 K 0.4 100 K 100 K
Change in Working Capital (187.0) (31.9) (130.0) 16.8 (44.3) (95.2) (67.2) 10.3 (81.1) (78.8) 5.7 (83.9) (42.9) (15.9) (34.8) (18.1) (55.8) (5.1) (3.8) (20.0) (25.1) (14.3) (5.9) (12.0) 1.0 (6.3) (4.7) (4.2) (0.9)
Cash From Operations 459.5 715.3 639.0 492.3 330.8 359.5 286.8 341.6 317.5 288.0 259.0 244.9 244.8 250.8 217.0 173.0 84.8 101.5 91.2 53.8 64.1 36.7 58.1 38.9 26.2 11.6 8.5 4.1 3.9
INVESTING CASH FLOW
Capital Expenditures (162.8) (149.3) (206.5) (304.2) (274.9) (150.8) (124.4) (93.9) (117.5) (97.0) (118.7) (128.1) (121.4) (123.9) (69.4) (57.9) (58.6) (35.4) (13.7) (12.6) (19.6) (59.1) (102.1) (39.4) (11.8) (10.5) (6.8) (9.7) (1.7)
Other Items 75.1 (577.4) 4.1 (149.1) 52.6 (60.6) (339.9) (85.1) (28.7) (310.6) (133.0) (172.8) (418.9) (91.6) (272.4) (152.6) (601.1) (130.1) (84.8) (38.5) 5.5 (5.7) 11.3 (5.6) (11.9) (1.2) 0.9 (28.6) 100 K
Cash From Investing Activities (87.7) (726.8) (202.4) (453.3) (222.3) (211.4) (464.3) (179.1) (146.2) (407.6) (251.7) (300.9) (540.3) (215.5) (341.7) (210.5) (659.7) (165.5) (98.5) (51.1) (14.1) (64.8) (90.8) (45.0) (23.7) (11.7) (5.9) (38.3) (1.6)
FINANCING CASH FLOW
Common Stock Repurchased 0 0 (100.0) (64.0) (74.5) (104.7) (61.0) 0 (20.8) (126.9) (86.0) (35.7) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Total Debt Repaid (436.8) (108.6) (41.3) (35.6) (505.4) 493.6 722.9 (8.1) (252.9) 325.3 (6.5) 249.2 (429.6) (50.2) (28.0) (5.0) 440.2 284.5 (5.5) 90.5 (4.0) 3.8 58.6 (5.9) 1.7 0.7 2.5 0.8 (1.2)
Dividends Paid 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Financing Activities 2.8 (17.4) (17.0) 41.8 (61.3) (32.9) (280.8) (8.8) 4.8 (17.7) (1.6) 13.0 118.9 3.8 6.7 (0.7) 11.5 7.7 0.5 0 0 0 3.6 0 0 0 0 0 0
Cash From Financing Activities (433.8) (125.8) (150.4) (74.3) (639.1) 360.4 387.2 (10.6) (258.6) 192.8 (68.8) 226.6 (310.6) (35.2) 629.2 12.8 494.1 303.2 3.0 95.6 (1.9) 6.1 66.2 14.8 3.6 1.8 3.2 31.9 (1.2)
CHANGE IN CASH
Net Change In Cash (62.6) (149.8) 282.5 (31.2) (529.7) 501.4 218.5 149.2 (102.7) 62.4 (63.7) 172.9 (607.3) 2.9 492.2 (14.0) (83.0) 238.7 (4.7) 97.4 54.1 (11.6) 32.5 9.1 5.8 2.0 2.3 (3.3) 1.7
FREE CASH FLOW
Free Cash Flow 296.7 565.9 432.5 188.0 56.0 208.7 162.4 247.7 200.0 191.0 140.3 116.8 123.4 126.8 147.6 115.1 26.2 66.1 77.5 41.2 44.5 (22.4) (44.0) (0.6) 14.4 1.1 1.7 (5.6) 2.2